Preventing relapse of advanced ovarian cancer with PARP inhibitors is now an established strategy. As data from pivotal ...

A coffee morning to support people who have been diagnosed with ovarian cancer is being held this Saturday, October 11, at ...

The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after first-line platinum therapies, driving demand for novel second- and later-line ...

Ovarian cancer is an abnormal growth of cells or tumors in the ovaries. Some forms of ovarian cancer are more aggressive than ...

More than 1,000 people marched to raise funds to support breast and ovarian cancer patients through the Gouverneur Breast and ...

Europe's health regulator has recommended the approval of GSK's cancer treatment Zejula as a first option to keep advanced ovarian cancer at bay in women who have responded to chemotherapy, the ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

The new test, called the risk of ovarian cancer algorithm (Roca), calculates a woman’s individual risk based on factors such ...

Surgeons who previously shared patients with physicians who frequently performed opportunistic salpingectomy (OS) were more likely to adopt the procedure themselves, according to a study published in ...

Ovarian cancer has been called “the silent killer” because its symptoms often go unnoticed or misdiagnosed. But the truth is, ...

Breast cancer was once a leading cause of death for Jewish women, but decades of research have led to a more than 90% ...

Ovarian cancer. It's often called the silent killer because its symptoms can be so easy to overlook. It's one of the top ...